Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets. | J Cancer Res Clin Oncol | 2023 | 37610673 | PubTator, text mining | PubMed |
| H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. | J Immunother Cancer | 2023 | 37553181 | PubTator, text mining | PubMed |
| The Price of Human Evolution: Cancer-Testis Antigens, the Decline in Male Fertility and the Increase in Cancer. | Int J Mol Sci | 2023 | 37511419 | PubTator, text mining | PubMed |
| Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37509293 | PubTator, text mining | PubMed |
| The MAGE A1-A10 Expression associated with Histopathological Findings of Malignant or Non-Malignant Cells in Peripheral Lung Tumors. | Asian Pac J Cancer Prev | 2023 | 37505763 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. | Onco Targets Ther | 2023 | 37425981 | PubTator, text mining | PubMed |
| A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma. | BMC Cancer | 2023 | 37422615 | PubTator, text mining | PubMed |
| Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers. | Front Immunol | 2023 | 37398650 | PubTator, text mining | PubMed |
| Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells. | Int J Mol Sci | 2023 | 37372979 | PubTator, text mining | PubMed |
| Non-Classical HLA Class 1b and Hepatocellular Carcinoma. | Biomedicines | 2023 | 37371767 | PubTator, text mining | PubMed |
| Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario. | Biomedicines | 2023 | 37371615 | PubTator, text mining | PubMed |
| T-Cell Engagers in Solid Cancers-Current Landscape and Future Directions. | Cancers (Basel) | 2023 | 37345160 | PubTator, text mining | PubMed |
| Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. | Cancers (Basel) | 2023 | 37345057 | PubTator, text mining | PubMed |
| Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer. | Mol Oncol | 2023 | 37341056 | PubTator, text mining | PubMed |
| Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions. | Front Immunol | 2023 | 37304305 | PubTator, text mining | PubMed |
| Vaccinating against cancer: getting to prime time. | J Immunother Cancer | 2023 | 37286302 | PubTator, text mining | PubMed |
| The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy. | Front Immunol | 2023 | 37275874 | PubTator, text mining | PubMed |
| Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation. | Medicina (Kaunas) | 2023 | 37241221 | PubTator, text mining | PubMed |
| DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer. | PLoS One | 2023 | 37200388 | PubTator, text mining | PubMed |
| Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes. | Cancers (Basel) | 2023 | 37190310 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=6